Compugen patents

Abstract: This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. Company is pursuing for COM9are part of its global patent strategy covering its innovative immuno-oncology pipeline. Compugen Announces Issuance of Two U. CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that a patent for. The present invention is directed to anti-PVRIG antibodies and methods of using same. You may not mirror any of the content from this site on another Web site or in any other media.

Patent Before Someone Else Does! Israel, the United States, and Europe. Just nailed the patent on our lead immune-onco drug. Blockade of PVRIG by COM7has demonstrated potent, reproducible enhancement of T cell activation, consistent with the desired. The following represents disclosure information provided by authors of this abstract.

The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. Jeanne has job listed on their profile. See the complete profile on LinkedIn and discover Jeanne’s connections and jobs at similar companies. Ofer Levy has filed for patents to protect the following inventions.

Additional fields are available via our API for commercial use. While Opdivo is a programmed death-(PD-1) immune checkpoint inhibitor. Mintz is a pioneer in the discovery of splice variants and an inventor of more than U. Nivolumab, a fully human immunoglobulin Gprogrammed death immune checkpoint inhibitor antibody, was active and generally well tolerated in patients with advanced solid tumors treated in a phase I trial with expansion cohorts.

It focuses its research and development on immuno-oncology and autoimmune diseases. Czaczkes Akselbrad was Chief Financial Officer of Packet Technologies Ltd. He has over years experience in the breeding of tomatoes and in molecular genomics research. It also discovered a VEGF variant protein (VEGF114) and was awarded related patents. The Lens serves almost all the patents and scholarly work in the world as a free, open and secure digital public goo with user privacy a paramount focus.

Spoke is the definitive source of curated information on millions of companies, people and industries. The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy. Summary of Facts and Submissions.

International patent application no. Director of Operations at the RD Division. Comprehensive research facility construction, coordination and operation. Senior Scientist in the Computational Chemistry and Drug Design Group, RD Division.

Development and advancement of an innovative concept of drug discovery. Prior to joining the Weizmann Institute, Prof. Sorek is also an author of numerous scientific publications in top-tier journals, and an inventor of more than patents. Ofer Haviv President and Chief Executive Officer. Image source: The Motley Fool.

At this time, all participants are in a listen-only mode. As a reminder, today's call is being recorded. Ladies and gentlemen, thank you for standing by.